Bioavailability and pharmacokinetics of bufadienolides-loaded lipid microspheres after different administrations to rats

European Journal of Lipid Science and Technology

Volumn 113, Issue 9, 2011, Pages 1095-1105

  Weng, Yan ^a   Jin, Jian ^b   Pan, Cheng ^a   Meng, Lingkuo ^a   Tang, Xing ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Bioavailability; Bufadienolides; Lipid microsphere; Pharmacokinetics; Stability

Indexed keywords

RATTUS;

EID: 80052648569     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.201100091     Document Type: Article

References (24)

1. Krylov, V. N., Study of cardiotonic effect of venom of the green toad Bufo viridis. J. Evol. Biochem. Physiol. 2002, 38, 223- 228.
2. Steyn, P. S., Heerden, F. R., Bufadienolides of plant and animal origin. Nat. Prod. Rep. 1998, 15, 397- 413.
3. Mor, A., Chartrel, N., Vaudry, H., Nicolas, P., Skin peptide tyrosine-tyrosine, a member of the pancreatic polypeptide family: isolation, structure, and endocrine activity. Proc. Natl. Acad. Sci. 1994, 91, 10295- 10299.
4. Clarke, B. T., The natural history of amphibian skin secretions, their normal functioning and potential medical applications. Biol. Rev. Camb. Philos. Soc. 1997, 72, 365- 379.
5. Zhang, L. S., Nakaya, K., Yoshida, T., Kuroiwa, Y., Bufalin as a potent inducer of differentiation of human myeloid leukemia cells. Biochem. Biophys. Res. Commun. 1991, 178, 686- 693.
6. Zhang, L. S., Nakaya, K., Yoshida, T., Kuroiwa, Y., Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers. Cancer Res. 1992, 52, 4634- 4641.
7. Hashimoto, S., Jing, Y., Kawazoe, N., Masuda, Y., et al. Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs. Leuk. Res. 1997, 21, 875- 883.
8. Li, F., Yang, R., Weng, Y., Tang, X., Preparation and evaluation of lyophilized liposome-encapsulated bufadienolides. Drug Dev. Ind. Pharm. 2009, 35, 1048- 1058.
9. Weng, Y., Li, F., Chen, W., Miao, Y. Q., Tang, X., Intravenous bufadienolides-loaded lipid microsphere for improving chemical stability. Eur. J. Lipid Sci. Technol. 2010, 112, 1190- 1199.
10. Okada, F., Kobayashi, A., Fujiwara, N., Takahashi, K., Bacteriostatic and bactericidal actions of antimicrobial drugs studied by microbial calorimetry. Biocontrol. Sci. 1999, 4, 35- 39.
11. Sathanandam, S. A., James, V. B., Wendy, T. H., Srinivasa, M., Jeffrey, W. F. P., Characterization of deltamethrin metabolism by rat plasma and liver microsomes. Toxicol. Appl. Pharmacol. 2006, 212, 156- 166.
12. Kim, E. J., Han, K. S., Lee, M. G., Intestinal first-pass effect of bumetanide in rats. Int. J. Pharm. 2000, 194, 193- 199.
13. Kim, J., Kim, S. H., Lee, M. G., Liver and gastrointestinal first-pass effects of azosemide in rats. J. Pharm. Pharmacol. 1997, 49, 878- 883.
14. Zhang, Y., Tang, X., Liu, X. L., Li, F., Lin, X., Simultaneous determination of three bufadienolides in rat plasma after intravenous administration of bufadienolides extract by ultra performance liquid chromatography electrospray ionization tandem mass spectrometry. Anal. Chim. Acta 2008, 610, 224- 231.
15. Santos Magalhaes, N. S., Cave, G., Seiller, M., Benita, S., The stability and in vitro release kinetics of a clofibride emulsion. Int. J. Pharm. 1991, 76, 225- 237.
16. Aloulou, Rodriguez, J. A., Fernandez, S., Oosterhout, D. V., et al., Exploring the specific features of interfacial enzymology based on lipase studies. Biochim. Biophys. Acta 2006, 1761, 995- 1013.
17. Harnisch, S., Müller, R. H., Adsorption kinetics of plasma proteins on oil-in-water emulsions for parenteral nutrition. Eur. J. Pharm. Biopharm. 2000, 49, 41- 46.
18. Ohmukai, Lipo-NSAID preparation. Adv. Drug Deliv. Rev. 1996, 20, 203- 207.
19. Toma, S., Hirai, Y., Sugimoto, C., Shoji, M., et al., Metabolic fate of bufalin and cinobufagin. Yakugaku Zasshi. 1991, 111, 687- 694.
20. Yamaguchi, H., Watanabe, K., Hayashi, M., Awazu, S., Effect of egg yolk phospholipids plasma elimination and tissue distribution of coenzyme Q10 administered in an emulsion to rats. J. Pharm. Pharmacol. 1984, 36, 768- 769.
21. Yanagikawa, Application of lipid particles as a novel carrier for various drugs. Jpn. J. Inflamm. 1982, 2, 251- 257.
22. Toma, S., Hirai, Y., Sugimoto, C., Shoji, M., et al., Metabolic fate of bufalin in rats. Yakugaku Zasshi. 1991, 111, 676- 686.
23. Li, F., Weng, Y., Wang, L., He, H., et al., The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers. Int. J. Pharm. 2010, 393, 203- 211.
24. Ma, X., Cui, J., Zheng, J., Guo, D., Microbial transformation of three bufadienolides by Penicillium aurantigriseum and its application for metabolite identification in rat. J. Mol. Catal. B: Enzym. 2007, 48, 42- 50.